Erythromycin Delayed-Release Capsules
»Erythromycin Delayed-Release Capsules contain not less than 90.0percent and not more than 115.0percent of the labeled amount of C37H67NO13.
Packaging and storage— Preserve in tight containers.
Identification— Prepare a test solution by mixing a quantity of finely ground Capsule contents with methanol to obtain a concentration of about 2.5mg of erythromycin per mL.Prepare a Standard solution of USP Erythromycin RSin methanol containing 2.5mg per mL.Apply separately 10µLof each solution to a thin-layer chromatographic plate (see Chromatography á621ñ)coated with a 0.25-mm layer of chromatographic silica gel.Place the plate in an unlined chromatographic chamber,and develop the chromatogram in a solvent system consisting of a mixture of methanol and chloroform (85:15)until the solvent front has moved about 7cm.Remove the plate from the chamber,mark the solvent front,and allow the solvent to evaporate.Spray the plate with a mixture of alcohol,p-methoxybenzaldehyde,and sulfuric acid (90:5:5).Heat the plate at 100for 10minutes,and examine the chromatogram,in which erythromycin appears as a black-to-purple spot:the RFvalue of the principal spot obtained from the test solution corresponds to that obtained from the Standard solution.
Drug release,Method Bá724ñ
Apparatus 1: 50rpm.
Times: 60minutes for Acid Stage;60minutes for Buffer Stage.
Procedure— Transfer the contents of 1Capsule to the apparatus.Proceed as directed for Acid Stage,900mLof 0.06Nhydrochloric acid being placed in the vessel instead of 1000mLof 0.1Nhydrochloric acid,and the apparatus being operated for 60minutes instead of 2hours.Do not perform an analysis at the end of the Acid stage.Continue as directed for Buffer Stage,900mLof the pH6.8phosphate buffer being used instead of 1000mL.Determine the amount of C37H67NO13dissolved after 120minutes by assaying a filtered portion of the solution under test as directed under Antibiotics—Microbial Assays á81ñ.
Tolerances— Not less than 80%(Q)of the labeled amount of C37H67NO13is dissolved in 120minutes.
Water,Method Iá921ñ: not more than 7.5%,20mLof methanol containing 10%of imidazole being used in place of methanol in the titration vessel.
Assay— Proceed as directed under Antibiotics—Microbial Assays á81ñ,using not less than 5Capsules blended for about 3minutes in a high-speed glass blender jar containing 200mLof methanol.Add 300mLof Buffer No.3,and blend again for about 3minutes.Dilute an accurately measured volume of this stock solution quantitatively with Buffer No.3to obtain a Test Dilutionhaving a concentration assumed to be equal to the median dose level of the Standard.
Auxiliary Information— Staff Liaison:William W.Wright,Ph.D.,Scientific Fellow
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28–NF23Page 758
Phone Number:1-301-816-8335